Mangalam Cement Limited (NSE:MANGLMCEM)

Verve Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 6, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	19,610	21,148	20,102	7,292	10,699	7,516
Market Cap Growth	5.21%	5.21%	175.66%	-31.84%	42.36%	87.70%
Enterprise Value	23,929	25,033	24,401	10,873	15,032	10,186
Last Close Price	713.05	769.85	729.81	263.65	383.31	276.77
PE Ratio	43.52	46.93	33.66	42.59	13.77	8.04
PS Ratio	1.17	1.26	1.17	0.41	0.68	0.58
PB Ratio	2.30	2.48	2.48	0.96	1.44	1.13
P/TBV Ratio	2.33	2.51	2.50	0.98	1.46	1.14
P/FCF Ratio	31.51	33.99	24.01	63.52	16.71	4.84
P/OCF Ratio	10.45	11.27	11.02	5.26	5.68	3.22
EV/Sales Ratio	1.42	1.49	1.41	0.60	0.96	0.78
EV/EBITDA Ratio	15.20	16.22	12.21	7.25	6.92	4.19
EV/EBIT Ratio	30.36	31.76	19.03	13.19	9.59	5.56
EV/FCF Ratio	38.45	40.23	29.15	94.71	23.48	6.55
Debt / Equity Ratio	0.74	0.74	0.75	0.82	0.85	0.95
Debt / EBITDA Ratio	3.98	3.98	3.00	4.09	2.87	2.58
Debt / FCF Ratio	10.08	10.08	7.26	54.13	9.81	4.07
Asset Turnover	0.79	0.79	0.85	0.92	0.83	0.76
Inventory Turnover	2.00	2.00	2.15	0.95	1.00	0.85
Quick Ratio	0.28	0.28	0.32	0.36	0.47	0.45
Current Ratio	0.82	0.82	0.85	0.86	1.04	1.05
Return on Equity (ROE)	5.42%	5.42%	7.62%	2.28%	11.02%	15.03%
Return on Assets (ROA)	2.33%	2.33%	3.95%	2.63%	5.18%	6.64%
Return on Capital (ROIC)	3.40%	3.40%	5.73%	3.75%	7.34%	9.31%
Return on Capital Employed (ROCE)	6.20%	6.20%	10.30%	6.80%	12.50%	15.20%
Earnings Yield	2.30%	2.13%	2.97%	2.35%	7.26%	12.44%
FCF Yield	3.17%	2.94%	4.16%	1.57%	5.98%	20.68%
Dividend Yield	0.21%	0.19%	0.21%	0.57%	0.39%	0.54%
Payout Ratio	9.15%	9.15%	6.91%	24.09%	5.15%	2.86%
Buyback Yield / Dilution	-	-	-	-	-	-3.01%
Total Shareholder Return	0.21%	0.19%	0.21%	0.57%	0.39%	-2.47%

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.